Abstract
Plasma prolactin concentrations were studied in 88 oophorectomised women who had been receiving mestranol or placebo for three to 11 years. Thirty one of them were also studied under basal conditions and by tests with thyrotrophin releasing hormone. Under basal conditions the mean prolactin concentration was higher in the oestrogen treated group but under non-rested, clinic conditions the difference was lost because of a rise in prolactin value in the placebo group only. Hence the groups showed a different prolactin response to the mild stress of clinic attendance but the same proportionate responsiveness to thyrotrophin releasing hormone. The data suggest that long term hormone replacement has no significant effect on circulating prolactin concentrations under non-rested, everyday conditions and that the prolactin stimulating effects of minor stress and oestrogen may share a similar mechanism.
Full text
PDF


Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Aitken J. M., Hart D. M., Lindsay R. Oestrogen replacement therapy for prevention of osteoporosis after oophorectomy. Br Med J. 1973 Sep 8;3(5879):515–518. doi: 10.1136/bmj.3.5879.515. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cowden E. A., Ratcliffe W. A., Beastall G. H., Ratcliffe J. G. Laboratory assessment of prolactin status. Ann Clin Biochem. 1979 May;16(3):113–121. doi: 10.1177/000456327901600126. [DOI] [PubMed] [Google Scholar]
- Davis J. R., Selby C., Jeffcoate W. J. Oral contraceptive agents do not affect serum prolactin in normal women. Clin Endocrinol (Oxf) 1984 Apr;20(4):427–434. doi: 10.1111/j.1365-2265.1984.tb03438.x. [DOI] [PubMed] [Google Scholar]
- Gambrell R. D., Jr, Maier R. C., Sanders B. I. Decreased incidence of breast cancer in postmenopausal estrogen-progestogen users. Obstet Gynecol. 1983 Oct;62(4):435–443. [PubMed] [Google Scholar]
- Hulka B. S., Chambless L. E., Deubner D. C., Wilkinson W. E. Breast cancer and estrogen replacement therapy. Am J Obstet Gynecol. 1982 Jul 15;143(6):638–644. doi: 10.1016/0002-9378(82)90108-9. [DOI] [PubMed] [Google Scholar]
- Jacobs H. S., Knuth U. A., Hull M. G., Franks S. Post-"pill" amenorrhoea--cause or coincidence? Br Med J. 1977 Oct 8;2(6092):940–942. doi: 10.1136/bmj.2.6092.940. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lind T., Cameron E. H., Hunter W. M. Serum prolactin, gonadotrophin and oestrogen levels in women receiving hormone replacement therapy. Br J Obstet Gynaecol. 1978 Feb;85(2):138–141. doi: 10.1111/j.1471-0528.1978.tb10468.x. [DOI] [PubMed] [Google Scholar]
- Mack T. M., Henderson B. E., Gerkins V. R., Arthur M., Baptista J., Pike M. C. Reserpine and breast cancer in a retirement community. N Engl J Med. 1975 Jun 26;292(26):1366–1371. doi: 10.1056/NEJM197506262922603. [DOI] [PubMed] [Google Scholar]
- Meites J., Lu K. H., Wuttke W., Welsch C. W., Nagasawa H., Quadri S. K. Recent studies on functions and control of prolactin secretion in rats. Recent Prog Horm Res. 1972;28:471–526. [PubMed] [Google Scholar]
- Noel G. L., Suh H. K., Stone J. G., Frantz A. G. Human prolactin and growth hormone release during surgery and other conditions of stress. J Clin Endocrinol Metab. 1972 Dec;35(6):840–851. doi: 10.1210/jcem-35-6-840. [DOI] [PubMed] [Google Scholar]
- Pearce J. M., McGarrick G., Chamberlain G. V., Jeffcoate S. L. Lack of effect of interview and gynaecological examination on plasma levels of prolactin and cortisol. Br J Obstet Gynaecol. 1980 May;87(5):366–369. doi: 10.1111/j.1471-0528.1980.tb04560.x. [DOI] [PubMed] [Google Scholar]
- Pike M. C., Henderson B. E., Krailo M. D., Duke A., Roy S. Breast cancer in young women and use of oral contraceptives: possible modifying effect of formulation and age at use. Lancet. 1983 Oct 22;2(8356):926–930. doi: 10.1016/s0140-6736(83)90450-6. [DOI] [PubMed] [Google Scholar]
- Sherman B. M., Harris C. E., Schlechte J., Duello T. M., Halmi N. S., VanGilder J., Chapler F. K., Granner D. K. Pathogenesis of prolactin-secreting pituitary adenomas. Lancet. 1978 Nov 11;2(8098):1019–1021. doi: 10.1016/s0140-6736(78)92339-5. [DOI] [PubMed] [Google Scholar]
- Vekemans M., Robyn C. The influence of exogenous estrogen on the circadian periodicity of circulating prolactin in women. J Clin Endocrinol Metab. 1975 May;40(5):886–889. doi: 10.1210/jcem-40-5-886. [DOI] [PubMed] [Google Scholar]
- Welsch C. W., Nagasawa H. Prolactin and murine mammary tumorigenesis: a review. Cancer Res. 1977 Apr;37(4):951–963. [PubMed] [Google Scholar]
- Wingrave S. J., Kay C. R., Vessey M. P. Oral contraceptives and pituitary adenomas. Br Med J. 1980 Mar 8;280(6215):685–686. doi: 10.1136/bmj.280.6215.685-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Yen S. S., Ehara Y., Siler T. M. Augmentation of prolactin secretion by estrogen in hypogonadal women. J Clin Invest. 1974 Feb;53(2):652–655. doi: 10.1172/JCI107600. [DOI] [PMC free article] [PubMed] [Google Scholar]
